Therefore, Cu2+ toxicity in AD was thought to be mediated by Aβ-bound Cu2+ inhibiting cytochrome-c oxidase and their potential to induce Tau protein phosphorylation and aggregation via cysteine residues (Ayton et al. 2013; Hayne et al. 2014). Here, MAPT is linked to Alzheimer disease.